转位的急性髓性白血病:分子致病,潜在的治疗方法和未来的方向
Pei Han Yu1, Ze Yan Zhang1, Yuan Yuan Kang1
1Department of Hematology of First Affiliated Hospital, and Department of Public Health, Zhejiang University School of Medicine, Hangzhou, China.
Biochemical pharmacology
|January 26, 2025
概括
在急性髓性白血病 (AML) 中准RUNX1/RUNX1T1融合蛋白提供了新的希望. 本综述探讨了包括小分子和PROTAC在内的新型向疗法,以打击t(8;21) AML的复发和耐药性.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 急性髓性白血病 (AML) 是一种复杂的血液癌症,具有显著的异质性.
- 基因重组是AML病例的一个子集的关键驱动因素.
- RUNX1/RUNX1T1融合蛋白破坏了正常的基因调节,导致白血病发生.
研究的目的:
- 审查RUNX1/RUNX1T1驱动型白血病的分子机制.
- 探索针对白血病的向治疗的最新进展.
- 确定更有效,更少毒性治疗的策略.
主要方法:
- 关于AML中的遗传异常的文献综述.
- 对RUNX1/RUNX1T1融合蛋白的分子机制的分析.
- 调查新兴的向疗法,包括小分子药物和PROTACs.
主要成果:
- RUNX1/RUNX1T1融合蛋白是AML病原体的核心.
- 尽管预后良好,但复发和抗化疗仍然是一个挑战.
- 目前没有针对RUNX1/RUNX1T1驱动的AML的特定向疗法.
结论:
- 针对RUNX1/RUNX1T1的向疗法对t(8;21) AML.有显著的希望.
- 小分子药物和PROTACs代表着有前途的治疗途径.
- 需要进一步的研究来开发有效和不那么有毒的治疗策略.
相关概念视频
Gene Therapy
22.1K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
22.1K
Blood Transfusion and Agglutination
13.0K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
13.0K
Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
Stem Cell Therapy for Tissue Regeneration
3.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
3.8K
Bone Marrow Sampling and Transplants
3.0K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
3.0K
Tissue Transplantation
1.4K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.4K


